Back to results
US 2026/0273105 A1Published application
Nucleic acid constructs and methods of use
AssigneesIntellia Therapeutics, Inc., Regeneron Pharmaceuticals, Inc.
InventorsJonathan Douglas Finn, Hon-Ren Huang
Life of this patent
Estimating the term…
Abstract
Nucleic acid constructs that allow insertion and/or expression of a sequence of interest, such as a transgene, are provided. Compositions and methods of using such constructs for expression of a polypeptide or therapeutic agent, for example, are also provided.
Claims21
1-81. (canceled)
A method of modifying a target locus in a human subject comprising providing a cell in the human subject with a bidirectional nucleic acid construct comprising:
- a) a first segment comprising a first coding sequence for a therapeutic polypeptide;
- and
- b) a second segment comprising a reverse complement of a second coding sequence for the therapeutic polypeptide,
- wherein the first coding sequence and the second coding sequence are heterologous to the target locus and the bidirectional nucleic acid construct does not comprise:
- (i) a promoter that drives the expression of the first coding sequence, (ii) a promoter that drives the expression of the second coding sequence, and (iii) a homology arm, and
- wherein expression of the first coding sequence or the second coding sequence produces the therapeutic polypeptide.
3 more elements
A viral vector comprising a bidirectional nucleic acid construct comprising:
- a) a first segment comprising a first coding sequence for a therapeutic polypeptide;
- and
- b) a second segment comprising a reverse complement of a second coding sequence for the therapeutic polypeptide,
- wherein the first coding sequence and the second coding sequence are heterologous to the target locus and the bidirectional nucleic acid construct does not comprise:
- (i) a promoter that drives the expression of the first coding sequence, (ii) a promoter that drives the expression of the second coding sequence, and (iii) a homology arm.
2 more elements
Dependencies are inferred from the claim text.